Overview
DEVA
?
Philipp Daniel Haas
See more contacts
Management of Companies and Enterprises
,
Pharmaceutical and Medicine Manufacturing
,
Holding companies, nec
,
Pharmaceutical preparations
?
?
Actual
$446.10 million
Actual
-5.5%
-98.58%
$29,729
DEC
?
?
Istanbul:DEVA
Contacts
Get in Touch with 10 Principals*
-
Philipp Daniel HaasChairperson
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$446.10 million
USD
Actual
1 USD = 34.6524 TRY
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $146 | $207 | $65 |
| Net Investing Cash | -$70 | -$169 | -$120 |
| Net Financing Cash | -$88 | -$9 | $20 |
| Net Change in Cash | -$12 | $29 | -$35 |
| Cash at Beginning of Period | $63 | $41 | $62 |
| Cash at End of Period | $28 | $63 | $29 |
| Capital Expenditure | -$91 | -$107 | -$67 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $28 | $63 | $29 |
| Accounts Receivable | $142 | $148 | $82 |
| Inventories | $136 | $171 | $114 |
| Other Current Assets | $48 | $98 | $54 |
| Asset Summary | |||
| Total Current Assets | $355 | $480 | $279 |
| Tangible Fixed Assets | $276 | $270 | $188 |
| Intangible Assets | $169 | $152 | $103 |
| Total Assets | $29,729 | $32,404 | $20,536 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $33 | $37 | $34 |
| Short-Term Debt | $149 | $198 | $137 |
| Other Current Liabilities | $39 | $53 | $21 |
| Liability Summary | |||
| Total Current Liabilities | $220 | $288 | $192 |
| Long-Term Debt | $ | $ | $11 |
| Other Long-Term Liabilities | $ | $ | $ |
| Total Liabilities | $257 | $319 | $260 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $6 | $6 | $6 |
| Retained Earnings | $427 | $438 | $214 |
| Equity Summary | |||
| Total Equity | $601 | $616 | $333 |
| Shares Outstanding | 200,019,288 | 200,019,288 | 200,019,288 |